Florence Day

Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial

S. Tubeuf, S. Hartley, A. Farrin, 2023, The Lancet.

Early vocational rehabilitation and psychological support for trauma patients to improve return to work (the ROWTATE trial): study protocol for an individually randomised controlled multicentre pragmatic trial

R. Morriss, A. Farrin, J. Kettlewell, 2024, Trials.